APA
Pérez-Ruiz E., Jiménez-Castro J., Berciano-Guerrero M., Valdivia J., Estalella-Mendoza S., Toscano F., Rodriguez de la Borbolla Artacho M., Garrido-Siles M., Martínez-Bautista M. J., Villatoro Roldan R., Rivas-Ruiz F., Nogales-Fernández E., Morales C., Pérez-Valderrama B., De la Cruz-Merino L. & Rueda A. (20210603). Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practice. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
Chicago
Pérez-Ruiz E, Jiménez-Castro J, Berciano-Guerrero M-A, Valdivia J, Estalella-Mendoza S, Toscano F, Rodriguez de la Borbolla Artacho M, Garrido-Siles M, Martínez-Bautista M J, Villatoro Roldan R, Rivas-Ruiz F, Nogales-Fernández E, Morales C, Pérez-Valderrama B, De la Cruz-Merino L and Rueda A. 20210603. Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practice. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
Harvard
Pérez-Ruiz E., Jiménez-Castro J., Berciano-Guerrero M., Valdivia J., Estalella-Mendoza S., Toscano F., Rodriguez de la Borbolla Artacho M., Garrido-Siles M., Martínez-Bautista M. J., Villatoro Roldan R., Rivas-Ruiz F., Nogales-Fernández E., Morales C., Pérez-Valderrama B., De la Cruz-Merino L. and Rueda A. (20210603). Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practice. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
MLA
Pérez-Ruiz E, Jiménez-Castro J, Berciano-Guerrero M-A, Valdivia J, Estalella-Mendoza S, Toscano F, Rodriguez de la Borbolla Artacho M, Garrido-Siles M, Martínez-Bautista M J, Villatoro Roldan R, Rivas-Ruiz F, Nogales-Fernández E, Morales C, Pérez-Valderrama B, De la Cruz-Merino L and Rueda A. Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practice. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 20210603.